The hepatocellular carcinoma Early Recurrence Score (ERS)-Ready for clinical implementation?

Liver Int. 2023 Nov;43(11):2346-2347. doi: 10.1111/liv.15741.

Authors

Helen L Reeves^{1

2}, John S Hammond³

Affiliations

¹ Newcastle University Translational and Clinical Research Institute, The Medical School, Newcastle-upon-Tyne, UK.
² The Liver Unit, Freeman Hospital, Newcastle-upon-Tyne, UK.
³ Department of HPB & Transplantation Surgery, Freeman Hospital, Newcastle-upon-Tyne, UK.

PMID: 37846805
DOI: 10.1111/liv.15741

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Hepatocellular* / pathology
Chronic Disease
Hepatectomy
Humans
Liver Neoplasms* / pathology
Neoplasm Recurrence, Local / pathology
Prognosis
Retrospective Studies

Grants and funding